This week’s research highlights a recurring market posture: AI and platform optionality are broadly priced into multiples while execution, cyclicality, and regulatory/pipeline risk drive neutral stances. Research across software, healthcare, and industrials emphasizes valuation discipline, monitoring of operational inflection points, and near‑term catalysts to de‑risk narratives.